581 related articles for article (PubMed ID: 28405879)
21. Mutations in CYP11B1 gene converting 11beta-hydroxylase into an aldosterone-producing enzyme are not present in aldosterone-producing adenomas.
Pilon C; Mulatero P; Barzon L; Veglio F; Garrone C; Boscaro M; Sonino N; Fallo F
J Clin Endocrinol Metab; 1999 Nov; 84(11):4228-31. PubMed ID: 10566677
[TBL] [Abstract][Full Text] [Related]
22. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
[TBL] [Abstract][Full Text] [Related]
23. Molecular and Epigenetic Control of Aldosterone Synthase, CYP11B2 and 11-Hydroxylase, CYP11B1.
Takeda Y; Demura M; Kometani M; Karashima S; Yoneda T; Takeda Y
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982850
[TBL] [Abstract][Full Text] [Related]
24. Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit?
Dekkers T; ter Meer M; Lenders JW; Hermus AR; Schultze Kool L; Langenhuijsen JF; Nishimoto K; Ogishima T; Mukai K; Azizan EA; Tops B; Deinum J; Küsters B
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1341-51. PubMed ID: 24758183
[TBL] [Abstract][Full Text] [Related]
25. Adrenocortical zonation in humans under normal and pathological conditions.
Nishimoto K; Nakagawa K; Li D; Kosaka T; Oya M; Mikami S; Shibata H; Itoh H; Mitani F; Yamazaki T; Ogishima T; Suematsu M; Mukai K
J Clin Endocrinol Metab; 2010 May; 95(5):2296-305. PubMed ID: 20200334
[TBL] [Abstract][Full Text] [Related]
26. Double somatic mutations in
Nanba K; Blinder AR; Udager AM; Hirokawa Y; Miura T; Okuno H; Moriyoshi K; Yamazaki Y; Sasano H; Yasoda A; Satoh-Asahara N; Rainey WE; Tagami T
Front Endocrinol (Lausanne); 2024; 15():1286297. PubMed ID: 38505749
[TBL] [Abstract][Full Text] [Related]
27. H-score of 11β-hydroxylase and aldosterone synthase in the histopathological diagnosis of adrenocortical tumors.
Yang Y; Xiao M; Song Y; Tang Y; Luo T; Yang S; He W; Cheng Q; Ma L; Zhang Y; He Y; Cao Y; Yang J; Peng B; Hu J; Li Q
Endocrine; 2019 Sep; 65(3):683-691. PubMed ID: 31332713
[TBL] [Abstract][Full Text] [Related]
28. The crosstalk between aldosterone and calcium metabolism in primary aldosteronism: A possible calcium metabolism-associated aberrant "neoplastic" steroidogenesis in adrenals.
Gao X; Yamazaki Y; Tezuka Y; Onodera Y; Ogata H; Omata K; Morimoto R; Nakamura Y; Satoh F; Sasano H
J Steroid Biochem Mol Biol; 2019 Oct; 193():105434. PubMed ID: 31351131
[TBL] [Abstract][Full Text] [Related]
29. Case Report: Primary Aldosteronism Due to Bilateral Aldosterone-Producing Micronodules With HISTALDO Classical and Contralateral Non-Classical Pathology.
Chen YJ; Peng KY; Chueh JS; Liao HW; Hsieh TY; Wu VC; Wang SM
Front Endocrinol (Lausanne); 2022; 13():816754. PubMed ID: 35399924
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemistry of aldosterone synthase leads the way to the pathogenesis of primary aldosteronism.
Nishimoto K; Koga M; Seki T; Oki K; Gomez-Sanchez EP; Gomez-Sanchez CE; Naruse M; Sakaguchi T; Morita S; Kosaka T; Oya M; Ogishima T; Yasuda M; Suematsu M; Kabe Y; Omura M; Nishikawa T; Mukai K
Mol Cell Endocrinol; 2017 Feb; 441():124-133. PubMed ID: 27751767
[TBL] [Abstract][Full Text] [Related]
31. Disordered CYP11B2 Expression in Primary Aldosteronism.
Gomez-Sanchez CE; Kuppusamy M; Reincke M; Williams TA
Horm Metab Res; 2017 Dec; 49(12):957-962. PubMed ID: 29202495
[TBL] [Abstract][Full Text] [Related]
32. Histopathology and Genetic Causes of Primary Aldosteronism in Young Adults.
Nanba K; Baker JE; Blinder AR; Bick NR; Liu CJ; Lim JS; Wachtel H; Cohen DL; Williams TA; Reincke M; Lyden ML; Bancos I; Young WF; Else T; Giordano TJ; Udager AM; Rainey WE
J Clin Endocrinol Metab; 2022 Aug; 107(9):2473-2482. PubMed ID: 35779252
[TBL] [Abstract][Full Text] [Related]
33. Impact of immunohistochemistry on the diagnosis and management of primary aldosteronism: An important tool for improved patient follow-up.
Volpe C; Hamberger B; Zedenius J; Juhlin CC
Scand J Surg; 2020 Jun; 109(2):133-142. PubMed ID: 30654730
[TBL] [Abstract][Full Text] [Related]
34. Presence of Subclinical Hypercortisolism in Clinical Aldosterone-Producing Adenomas Predicts Lower Clinical Success.
Peng KY; Liao HW; Chan CK; Lin WC; Yang SY; Tsai YC; Huang KH; Lin YH; Chueh JS; Wu VC
Hypertension; 2020 Nov; 76(5):1537-1544. PubMed ID: 32921192
[TBL] [Abstract][Full Text] [Related]
35. Histological Characterization of Aldosterone-producing Adrenocortical Adenomas with Different Somatic Mutations.
Ono Y; Yamazaki Y; Omata K; Else T; Tomlins SA; Rhayem Y; Williams TA; Reincke M; Carling T; Monticone S; Mulatero P; Beuschlein F; Ito S; Satoh F; Rainey WE; Sasano H
J Clin Endocrinol Metab; 2020 Mar; 105(3):e282-9. PubMed ID: 31789380
[TBL] [Abstract][Full Text] [Related]
36. Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks.
Nanba K; Omata K; Gomez-Sanchez CE; Stratakis CA; Demidowich AP; Suzuki M; Thompson LDR; Cohen DL; Luther JM; Gellert L; Vaidya A; Barletta JA; Else T; Giordano TJ; Tomlins SA; Rainey WE
Hypertension; 2019 Apr; 73(4):885-892. PubMed ID: 30739536
[TBL] [Abstract][Full Text] [Related]
37. PRKACA Somatic Mutations Are Rare Findings in Aldosterone-Producing Adenomas.
Rhayem Y; Perez-Rivas LG; Dietz A; Bathon K; Gebhard C; Riester A; Mauracher B; Gomez-Sanchez C; Eisenhofer G; Schwarzmayr T; Calebiro D; Strom TM; Reincke M; Beuschlein F
J Clin Endocrinol Metab; 2016 Aug; 101(8):3010-7. PubMed ID: 27270477
[TBL] [Abstract][Full Text] [Related]
38. Intratumoral heterogeneity of steroidogenesis in aldosterone-producing adenoma revealed by intensive double- and triple-immunostaining for CYP11B2/B1 and CYP17.
Nakamura Y; Kitada M; Satoh F; Maekawa T; Morimoto R; Yamazaki Y; Ise K; Gomez-Sanchez CE; Ito S; Arai Y; Dezawa M; Sasano H
Mol Cell Endocrinol; 2016 Feb; 422():57-63. PubMed ID: 26597777
[TBL] [Abstract][Full Text] [Related]
39. Different expression of 11β-hydroxylase and aldosterone synthase between aldosterone-producing microadenomas and macroadenomas.
Ono Y; Nakamura Y; Maekawa T; Felizola SJ; Morimoto R; Iwakura Y; Kudo M; Seiji K; Takase K; Arai Y; Gomez-Sanchez CE; Ito S; Sasano H; Satoh F
Hypertension; 2014 Aug; 64(2):438-44. PubMed ID: 24842915
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of Somatic Mutations in Aldosterone-Producing Adenomas in Japanese Patients.
Nanba K; Yamazaki Y; Bick N; Onodera K; Tezuka Y; Omata K; Ono Y; Blinder AR; Tomlins SA; Rainey WE; Satoh F; Sasano H
J Clin Endocrinol Metab; 2020 Nov; 105(11):e4066-73. PubMed ID: 32844168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
